| Description | Bafrekalant is a diazabicyclo-substituted imidazo[1,2-a]pyrimidine derivative that can be used to study sleep-related breathing disorders such as obstructive and central sleep apnoea and snoring. |
| molecular weight | 531.05 |
| Molecular formula | C29H31ClN6O2 |
| CAS | 2256770-44-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 225.0 mg/mL (423.7 mM ), Sonication is recommended. |
| References | 1. Martina Delbeck, et al. Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders. WO2018228907A1. |